WAINUA

This brand name is authorized in United States

Active ingredients

The drug WAINUA contains one active pharmaceutical ingredient (API):

1 Eplontersen UNII 0GRZ0F5XJ6 - EPLONTERSEN

Eplontersen is an antisense oligonucleotide-GalNAc conjugate that causes degradation of mutant and wild-type TTR mRNA through binding to the TTR mRNA, which results in a reduction of serum TTR protein and TTR protein deposits in tissues. Read about Eplontersen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
WAINUA Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX21		N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 0310-9400